You may qualify for an inpatient research study at the National Institutes of Health (NIH). Researchers at the National Institute of Mental Health (NIMH) are studying an investigational drug, HNK, to learn if it can help relieve symptoms of Major Depressive Disorder (MDD).
About the Study
- Ages 18–70
- Must have MDD
- Conducted at the NIH Clinical Center in Bethesda, MD
- Lasts 12- to 14-week
- Includes IV infusions, brain scans, and mood assessments
- One set of infusions will be the study drug (HNK), and one will be a placebo
- Compensation up to $5,000
Help researchers understand how depression works and how to treat it better. Your participation could lead to more effective treatments and bring hope to others living with depression.
Location
The NIH Clinical Center is in Bethesda, Maryland, conveniently accessible via the Metro Red Line (Medical Center stop).
For More Information
NIH Clinical Center Office of Patient Recruitment
833-JOIN-NIH
TTY users dial 7-1-1
Email: ccopr@nih.gov
Or go online
Refer to NIH study # 001602-M
Department of Health and Human Services
National Institutes of Health Clinical Center (CC)
National Institute of Mental Health (NIMH)